Biora Therapeutics, Inc. (PNK: BIORQ) Stock Competitors & Peer Comparison

Biora Therapeutics, Inc. (PNK: BIORQ) plays a significant role within the Healthcare sector. Its performance on the PNK reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BIORQ stands at 905. In comparison, SGMO has a market cap of 30.7M. Regarding current trading prices, BIORQ is priced at $0.00 on the PNK, while SGMO trades at $0.07.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BIORQ currently has a P/E ratio of N/A, whereas SGMO's P/E ratio is -0.20. In terms of profitability, BIORQ's ROE is +1.22%, compared to SGMO's ROE of +66.86%. Regarding short-term risk, BIORQ is less volatile compared to SGMO. This indicates lower risk in terms of short-term price fluctuations for BIORQ.Check SGMO's competition here

Biora Therapeutics, Inc. (PNK: BIORQ) plays a significant role within the Healthcare sector. Its performance on the PNK reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BIORQ stands at 905. In comparison, ADTX has a market cap of 3.7M. Regarding current trading prices, BIORQ is priced at $0.00 on the PNK, while ADTX trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BIORQ currently has a P/E ratio of N/A, whereas ADTX's P/E ratio is N/A. In terms of profitability, BIORQ's ROE is +1.22%, compared to ADTX's ROE of +9.26%. Regarding short-term risk, BIORQ is less volatile compared to ADTX. This indicates lower risk in terms of short-term price fluctuations for BIORQ.Check ADTX's competition here

Biora Therapeutics, Inc. (PNK: BIORQ) plays a significant role within the Healthcare sector. Its performance on the PNK reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BIORQ stands at 905. In comparison, ITRMF has a market cap of 2.7M. Regarding current trading prices, BIORQ is priced at $0.00 on the PNK, while ITRMF trades at $0.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BIORQ currently has a P/E ratio of N/A, whereas ITRMF's P/E ratio is -0.07. In terms of profitability, BIORQ's ROE is +1.22%, compared to ITRMF's ROE of +4.42%. Regarding short-term risk, BIORQ is less volatile compared to ITRMF. This indicates lower risk in terms of short-term price fluctuations for BIORQ.Check ITRMF's competition here

Biora Therapeutics, Inc. (PNK: BIORQ) plays a significant role within the Healthcare sector. Its performance on the PNK reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BIORQ stands at 905. In comparison, CASIF has a market cap of 2.6M. Regarding current trading prices, BIORQ is priced at $0.00 on the PNK, while CASIF trades at $0.13.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BIORQ currently has a P/E ratio of N/A, whereas CASIF's P/E ratio is -0.05. In terms of profitability, BIORQ's ROE is +1.22%, compared to CASIF's ROE of +2.04%. Regarding short-term risk, BIORQ is similarly volatile compared to CASIF. This indicates similar risk in terms of short-term price fluctuations for BIORQ.Check CASIF's competition here

Biora Therapeutics, Inc. (PNK: BIORQ) plays a significant role within the Healthcare sector. Its performance on the PNK reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BIORQ stands at 905. In comparison, OCEA has a market cap of 237.3K. Regarding current trading prices, BIORQ is priced at $0.00 on the PNK, while OCEA trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BIORQ currently has a P/E ratio of N/A, whereas OCEA's P/E ratio is N/A. In terms of profitability, BIORQ's ROE is +1.22%, compared to OCEA's ROE of +0.04%. Regarding short-term risk, BIORQ is less volatile compared to OCEA. This indicates lower risk in terms of short-term price fluctuations for BIORQ.Check OCEA's competition here

Biora Therapeutics, Inc. (PNK: BIORQ) plays a significant role within the Healthcare sector. Its performance on the PNK reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BIORQ stands at 905. In comparison, AFMDQ has a market cap of 1.6K. Regarding current trading prices, BIORQ is priced at $0.00 on the PNK, while AFMDQ trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BIORQ currently has a P/E ratio of N/A, whereas AFMDQ's P/E ratio is N/A. In terms of profitability, BIORQ's ROE is +1.22%, compared to AFMDQ's ROE of -1.01%. Regarding short-term risk, BIORQ is similarly volatile compared to AFMDQ. This indicates similar risk in terms of short-term price fluctuations for BIORQ.Check AFMDQ's competition here